Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Evofem Inc drug PHEXXI appeared first on DrugPat…
New patent expiration for Evofem Inc drug PHEXXI Read Post »
Annual Drug Patent Expirations for NORMOCARB+HF+25 Normocarb Hf 25 is a drug marketed by Dialysis Sups and is included in one NDA. There is one patent protecting this drug. This…
The post New patent expiration for Dialysis Sups drug NORMOCARB HF 25 app…
New patent expiration for Dialysis Sups drug NORMOCARB HF 25 Read Post »
Annual Drug Patent Expirations for ZOLINZA Zolinza is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Msd Sub drug ZOLINZA appeared first on DrugPatentWa…
ZOLINZA (vorinostat) Msd sub merck Patent: 8,067,472 Expiration: Mar 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Patent E…
Drug Patent Expirations for the Week of February 26, 2023 Read Post »
Annual Drug Patent Expirations for YOSPRALA Yosprala is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Genus Lifesciences drug YOSPRALA ap…
New patent expiration for Genus Lifesciences drug YOSPRALA Read Post »
LEQVIO (inclisiran sodium) Novartis Patent: 8,232,383 Expiration: Feb 20, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pat…
Drug Patent Expirations for the Week of February 19, 2023 Read Post »
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are seven…
The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on Dr…
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are twenty-five patents protecting…
The post New patent expiration for NOVO drug SAXENDA appeared first o…
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post New patent expiration for Merck Sharp drug TEMODAR appeared first on Dr…
New patent expiration for Merck Sharp drug TEMODAR Read Post »
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post New patent expiration for Merck Sharp drug TEMODAR appeared first on Dr…
New patent expiration for Merck Sharp drug TEMODAR Read Post »